Musclepharm Corp

Musclepharm — Investor Presentation (March 2013)

17 slides from Musclepharm's investor presentation, Mar 14, 2013

  1. Slide 1: Company Presentation

    COMPANY PRESENTATION

  2. Slide 2: Slide 2

  3. Slide 3: Table of Contents

    MUSCLEPHARM, MUSCLEPHARM, MUSCLEPHARM, TABLE OF CONTENTS FORWARD LOOKING STATEMENT ‘OUR COMPANY ‘OUR MANAGEMENT (MARKET ANALYSIS. INDUSTRY OVERVIEW ‘ADVISORY BOARD ‘CORPORATE OFFICE DISTRIBUTION FOOTPRINT AWARDS INNOVATION & NEW PRODUCTS (MARKETING & BRANDING STRATEGY GROWTH STRATEGY ‘COMPANY GoALS.

  4. Slide 4: Forward Looking Statement

    MUSCLEPHARM, Information included hersin contain forward looking statamants, Forward-looking statements are idantfieg by words such ag “expect, “plan,” -will” “should “could,” “anticipate, “estimato," and other similar expressions. Forward looking statements involve significant risks and uncertainti

  5. Slide 5: Our Company

    Founded in 2008, MusclePharm is a healthy liestyle company that develops and manufactures nutritional supplements that address active Hfestyles, inckading muscle building, weight loss ané maintaining general fitness thraugh'a daily nutritional supplement rogimen. We currantly have 20 products that a

  6. Slide 6: Our Management

    NP MUSCLEPHARM, MUSCLEPHARM, TP OUR MANAGEMENT Brad Pyatt- CEO/Founder/Co-Chair John Bluher EVP/COO/Co-Chaie ‘Significant Expariance in Both the Sports Nutrition and Mult Disciplinary Senior Managomant Background Exercise Sonee Fads Foundar of MusclePharm and CED, 2008 - Present Former NEL Player (7

  7. Slide 7: Market Analysis and Industry Overview

    NP MUSCLEPHARM, MARKET ANALYSIS SUMMARY ‘The market for sport nutritionals and supplements is eubstantial. Andi one of the fastest-growing ‘segments of the health supplamant markat investors can expect double digit markat growth through 20131 ‘According to BEC Research, the global market for sports

  8. Slide 8: Advisory Board

    NP MUSCLEPHARM, MUSCLEPHARM, TP MUSCLEPHARM ADVISORY BOARD | ‘UELING ae meee RSPR THLETES DIRECTOR & DEVELOPMENT AND CHIEF SCIENTIFIC FORMULATOR RESEARCH DIRECTOR > tT fo “ As Cha Formulator and Asa tstad matical (hist Medica Director Or Caungal Dr Moora ie LF Ld MourobiPaveasltrings FormerUSheotant

  9. Slide 9: Corporate Office

    MP od TE OFFICE BUILDING PERFECT ATHLETE a % ORs SPORTS SCIENCE CENTER RESEARCH INSTITUTE BM

  10. Slide 10: Distribution Footprint

    DISTRIBUTION FOOTPRINT THE ATHLETES COMPANY ed

  11. Slide 11: GNC 2012 Vendor Awards

    GNC = WELL SPORTS GNC 2012 VENDOR AWARDS ARE CREATED THROUGH AN ADVANCED PROTOCOL WHICH UTILIZES THE EXPERTISE OF TOP. NUTRITIONAL SCIENTISTS. TaN B

  12. Slide 12: Innovation & New Products

    ASSAULT ENERGY SHOTS: NITRATE SERIES: FOR CONVENIENCE STORES REVOLUTIONARY ION-3 TECHNOLOGY INNOVATION & NEW PRODUCTS INNOVATION: FEMALE ONLY FITNESS LINE UFC FIGHTSTACK: COMBINATION OF FIVE OF OUR MOST SUCCESSFUL PRODUCTS i a FIGHT 6 aT ROE

  13. Slide 13: Marketing & Branding Strategy

    NP MUSCLEPHARM, MUSCLEPHARM, IVE MARKETING & BUILT BRANDING STRATEGY THIS iP © Brand MuselePharm as the “must have fitness brand for workout enthusiasts and alte athletes. We soak tobe knawn as the athlete's company runby athletes who create their products for ‘thor athletes both professional and am

  14. Slide 14: Growth Strategy and Company Goals

    NP MUSCLEPHARM, MUSCLEPHARM, TP GROWTH STRATEGY COMPANY GOALS + nore ou product slatbutlon and alos IF YOU BUILD IT THEY WILL COME - trough iereasad markt panaratlons bath 2011 ACCOMPLISHED: ‘dmasticaly ard ntrnationali, “Bult the brand Us markatng and UEC rlaonship “Open dstabuton stannels using as

  15. Slide 15: Sales & Margin Improvement; Capitalization Table

    iP MUSCLEPHARM, SALES & MARGIN IMPROVEMENT ‘SALES & MARGIN INCREASE DISCOUNTS DROP 2008 2010 201. 2012 2013 P MIGROSSSALES DISCOUNTS PROMOS ——DISCOUNT% —E-GROSS MARGIN % ‘Not Soles (calculated in accordance with GAAP) has grown from 2008 through the third quarter of 2012 ata compound annual growth r

  16. Slide 16: min

    min vamp Va

  17. Slide 17: MusclePharm

    niR ow Bae MUSCLEPHARM,

MusclePharm — Investor Presentation (March 2013) on 6ix